BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18171992)

  • 1. Activation of epidermal akt by diverse mouse skin tumor promoters.
    Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
    Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
    Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
    Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
    Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters.
    Wang XJ; Warren BS; Rupp T; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1994 Dec; 15(12):2795-803. PubMed ID: 8001237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.
    Saleem M; Afaq F; Adhami VM; Mukhtar H
    Oncogene; 2004 Jul; 23(30):5203-14. PubMed ID: 15122342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters.
    Imamoto A; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1990 Sep; 11(9):1543-9. PubMed ID: 2401043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice.
    Rho O; Kiguchi K; Jiang G; DiGiovanni J
    Mol Carcinog; 2014 Nov; 53(11):871-82. PubMed ID: 24114993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion.
    Imamoto A; Beltrán LM; DiGiovanni J
    Mol Carcinog; 1991; 4(1):52-60. PubMed ID: 2009135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes.
    Li L; Sampat K; Hu N; Zakari J; Yuspa SH
    J Biol Chem; 2006 Feb; 281(6):3237-43. PubMed ID: 16338928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
    Shrotriya S; Kundu JK; Na HK; Surh YJ
    Cancer Res; 2010 Mar; 70(5):1932-40. PubMed ID: 20179211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric black tea polyphenols modulate the localization and activity of 12-O-tetradecanoylphorbol-13-acetate-mediated kinases in mouse skin: mechanisms of their anti-tumor-promoting action.
    Kumar G; Dange P; Kailaje V; Vaidya MM; Ramchandani AG; Maru GB
    Free Radic Biol Med; 2012 Sep; 53(6):1358-70. PubMed ID: 22841871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
    Wheeler DL; Ness KJ; Oberley TD; Verma AK
    Cancer Res; 2003 Oct; 63(19):6547-55. PubMed ID: 14559850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes.
    Maldve RE; Fischer SM
    Mol Carcinog; 1996 Dec; 17(4):207-16. PubMed ID: 8989914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W; Sharif TR; Houghton PJ; Sharif M
    Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.